Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Context Therapeutics (6K9) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Ct-202Colorectal Cancer, Urothelial Cancer, Triple Negative Breast Cancer (Tnbc)Phase INot Yet RecruitingA Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial CancersApr 16, 2026―
Ct-95Epithelial Ovarian Cancer, Colorectal Cancer, Cholangiocarcinoma Non-Resectable, Mesothelin-Expressing Tumors, Malignant Pleural Mesothelioma, Advanced, Malignant Peritoneal Mesothelioma, Advanced, Pancreatic Adenocarcinoma Advanced Or Metastatic, Lung Adenocarcinoma Metastatic, Cholangiocarcinoma Advanced, Mesothelin-Expressing Advanced Cancers, Mesothelin-Positive Advanced Malignant Solid TumorsPhase IRecruitingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionDec 18, 2024
Ctim-76Endometrial Cancer, Platinum-Resistant Ovarian Cancer, Testicular CancerPhase IRecruitingA Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsJul 16, 2024
Elacestrant, OnapristoneBreast Cancerphase1AndPhase2WithdrawnA Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast CancerMay 30, 2023―
Elacestrant, OnapristoneBreast Cancerphase1AndPhase2TerminatedStudy of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast CancerNov 03, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Context Therapeutics, Inc. (DE:6K9) have in its pipeline
Context Therapeutics DE:6K9 is currently developing the following drugs: Ct-202, Ct-95, Ctim-76, Elacestrant, Onapristone. These drug candidates are in various stages of clinical development as the company works toward FDA approval.